CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-06 | Conterno Enrique A Chief Executive Officer | Shares withheld for taxes | −1,536 | $13.93 | $21K | 132,704 |
| 2022-01-03 | Eisner Mark Chief Medical Officer | Shares withheld for taxes | −7,043 | $14.82 | $104K | 98,139 |
| 2022-01-03 | Chung Christine SVP, China Operations | Shares withheld for taxes | −5,284 | $14.82 | $78K | 209,439 |
| 2021-12-22 | Wettig Thane Chief Commercial Officer | Shares withheld for taxes | −517 | $14.97 | $8K | 47,682 |
| 2021-12-06 | Chung Christine SVP, China Operations | Shares withheld for taxes | −2,668 | $14.19 | $38K | 214,723 |
| 2021-12-01 | Eisner Mark Chief Medical Officer | Shares withheld for taxes | −4,338 | $12.65 | $55K | 105,182 |
| 2021-10-06 | Conterno Enrique A Chief Executive Officer | Shares withheld for taxes | −1,859 | $10.20 | $19K | 134,239 |
| 2021-10-04 | Chung Christine SVP, China Operations | Grant or award | +54,170 | 217,391 | ||
| 2021-10-04 | Chung Christine SVP, China Operations | Grant or award · Stock Option (Right to Buy) | +32,360 | 32,360 | ||
| 2021-10-04 | Eisner Mark Chief Medical Officer | Grant or award | +74,520 | 109,520 | ||
| 2021-10-04 | Eisner Mark Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +44,520 | 44,520 | ||
| 2021-09-22 | Wettig Thane Chief Commercial Officer | Shares withheld for taxes | −620 | $10.18 | $6K | 48,196 |
| 2021-09-15 | KEARNS THOMAS F JR Director | Sale | −13,100 | $11.58 | $152K | 39,764 |
| 2021-09-07 | Cotroneo Pat Executive Advisor & Former CFO | Shares withheld for taxes | −2,141 | $12.41 | $27K | 274,536 |
| 2021-09-07 | Chung Christine SVP, China Operations | Shares withheld for taxes | −2,030 | $12.41 | $25K | 165,251 |
| 2021-09-07 | Graham Juan Chief Financial Officer | Grant or award | +35,000 | 36,400 | ||
| 2021-09-07 | Graham Juan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +196,000 | 196,000 | ||
| 2021-08-26 | Wettig Thane Chief Commercial Officer | Purchase | +3,100 | $11.53 | $36K | 48,816 |
| 2021-07-06 | Conterno Enrique A Chief Executive Officer | Shares withheld for taxes | −1,859 | $25.06 | $47K | 136,098 |
| 2021-06-22 | Wettig Thane Chief Commercial Officer | Shares withheld for taxes | −2,593 | $27.65 | $72K | 45,716 |
Page 14 of 16 · 320 trades